Thus, targeting SIRT3 in pancreatic cancer represents a critical axis in regulating tumorigenesis, given its involvement in mitochondrial homeostasis, oxidative stress regulation and metabolic adaptation. The gene discussed is SIRT3; the disease is familial pancreatic carcinoma.